Scientists from the University of Birmingham have established an important two-year collaborative project with major pharmaceutical company GlaxoSmithKline (GSK) to look at the effects of cigarette and e-cigarette smoking on lung inflammation and cells.
Scientists at the University of Birmingham have developed a type of eye drop which could potentially revolutionise the treatment of one of the leading causes of blindness in the UK.
The NIHR Birmingham Biomedical Research Centre (BRC) opened on 1 April 2017 with the aim of accelerating the access to, and adoption of, drugs, devices and diagnostics tests for patients living with chronic inflammatory disease, driven by cutting edge experimental medicine.
The University of Birmingham has purchased 9.9acres of land in the Selly Oak area to develop a brand new Life Sciences Park.
Research led by University of Birmingham scientists has found that people suffering from the adrenal disorder known as Addison's disease suffer from an immune system defect that makes them prone to potentially deadly respiratory infections.